Dermatosis Papulosa Nigra

Back

Practice Essentials

Dermatosis papulosa nigra (DPN) is a benign cutaneous condition common among Black people. It is usually characterized by multiple, small, hyperpigmented, asymptomatic papules on the face of adult Blacks. Histologically, dermatosis papulosa nigra resembles seborrheic keratoses. In fact, some authors consider DPN to be a subtype of seborrheic keratoses.[1]

The condition may be cosmetically undesirable to some patients. See the image below.



View Image

Dermatosis papulosa nigra. Courtesy of DermNet New Zealand (http://www.dermnetnz.org/assets/Uploads/lesions/dpn2.jpg).

Pathophysiology

The exact pathophysiology of dermatosis papulosa nigra is not known. 

Dermatosis papulosa nigra is likely to be genetically determined, with 40-54% of patients having a family history of involvement. Dermatosis papulosa nigra is believed to be caused by a nevoid developmental defect of the pilosebaceous follicle. Hairston et al have suggested that dermatosis papulosa nigra should be classified within the group of epithelial nevi.[2]

DPN shares a mutation in FGFR3 with seborrheic keratoses, although DPN does not involve a mutation in PIK3CA, unlike seborrheic keratoses.[3]

Prognosis

The prognosis for patients with dermatosis papulosa nigra is excellent since it is not a premalignant condition nor is it associated with any underlying systemic disease. However, lesions of dermatosis papulosa nigra show no tendency to regress spontaneously, and they gradually may increase in number and size with age.

Presentation

Lesions usually begin during puberty. They tend to increase steadily in number and size as the individual ages.

Dermatosis papulosa nigra is characterized by multiple, firm, smooth, dark brown to black, flattened papules that measure 1-5 mm in diameter. Lesions occur mainly on the malar area of the face and the forehead, although they also may be found on the neck, upper back, and chest. A small percentage of patients have similar lesions on the upper trunk. Scaling, crusting, and ulceration do not occur.

Histologic findings

Lesions of dermatosis papulosa nigra have the histologic appearance of seborrheic keratoses; they display hyperkeratosis, irregular acanthosis, keratin-filled invaginations of the epidermis (horn cysts), and marked hyperpigmentation of the basal layer. Although most lesions are of the acanthotic type and show thick interwoven tracts of epidermal cells, they may have a reticulated pattern in which the tracts consist of a double row of basaloid cells.

Treatment

No treatment generally is indicated for dermatosis papulosa nigra unless lesions are cosmetically undesirable. Aggressive therapeutic modalities have been complicated by postoperative hyperpigmentation or hypopigmentation or scarring. Keloid formation is a potential complication. Therefore, conservative treatment is advisable.

Abrasive curettage with or without anesthesia,[4]  superficial liquid nitrogen cryotherapy, and electrodesiccation followed by curettage have been shown to be effective.

Laser therapy has also been reported,[5, 6, 7]  and it is becoming increasingly more common as a treatment modality.[8] Specifically, Furukawa et al treated 3 female Japanese patients with carbon dioxide laser for 5-10 months with good results.[9]  Treatments with 532 nm diode laser, 532 nm potassium-titanylphosphate laser, 585 nm pulsed dye laser, 1064 nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser, 10,600 nm carbon dioxide laser, and 1550 nm erbium-doped fractionated laser have all been reported as successful.[10]

Both EMLA (topical lidocaine/prilocaine cream) and LMX (topical lidocaine cream) are effective for providing topical anesthesia.[11]  Use caution with all therapies to minimize the depth of treatment.

Epidemiology

Frequency

Whereas earlier US studies revealed a 10% frequency in adult Black persons, more recent data suggest a frequency of approximately 35% in this population.[3] Data pertaining to the international frequency of dermatosis papulosa nigra are insufficient.

Race

Dermatosis papulosa nigra affects up to 35% of the African American population.[12] Black persons with a fair complexion have the lowest frequency of involvement.[13]  The disease seems to be more common in people with Fitzpatrick skin type VI. Dermatosis papulosa nigra also occurs among Asians, although the exact incidence is unknown. Specifically, the condition has been reported in persons of African, Han Chinese,[14] Filipino, and Vietnamese descent.[3]  There has been a single reported case in a White child.[15]

Sex

Females are affected more frequently than males.[13]

Age

Dermatosis papulosa nigra usually begins in adolescence and is rare in persons younger than 7 years.[16]  However, the condition has been recorded in patients as young as 3 years of age.[3] The incidence of dermatosis papulosa nigra, as well as the number and size of individual lesions, increases with age.

Author

Mehran Nowfar-Rad, MD, Facey Medical Group

Disclosure: Nothing to disclose.

Coauthor(s)

Frederick Fish, MD, Director, Department of Dermatology and Cutaneous Surgery, St Paul Ramsey Medical Center; Associate Clinical Professor, Department of Dermatology, University of Minnesota

Disclosure: Nothing to disclose.

Specialty Editors

Michael J Wells, MD, FAAD, Dermatologic/Mohs Surgeon, The Surgery Center at Plano Dermatology

Disclosure: Nothing to disclose.

Edward F Chan, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Kathryn Schwarzenberger, MD, Associate Professor of Medicine, Division of Dermatology, University of Vermont College of Medicine; Consulting Staff, Division of Dermatology, Fletcher Allen Health Care

Disclosure: Nothing to disclose.

References

  1. Metin SA, Lee BW, Lambert WC, Parish LC. Dermatosis papulosa nigra: a clinically and histopathologically distinct entity. Clin Dermatol. 2017 Sep - Oct. 35 (5):491-496. [View Abstract]
  2. Hairston MA Jr, Reed RJ, Derbes VJ. Dermatosis papulosa nigra. Arch Dermatol. 1964 May. 89:655-8. [View Abstract]
  3. Xiao A, Muse ME, Ettefagh L. Dermatosis Papulosa Nigra. 2022 Jan. [View Abstract]
  4. Kauh YC, McDonald JW, Rapaport JA, Ruschak PJ, Luscombe HA. A surgical approach for dermatosis papulosa nigra. Int J Dermatol. 1983 Dec. 22(10):590-2. [View Abstract]
  5. Schweiger ES, Kwasniak L, Aires DJ. Treatment of dermatosis papulosa nigra with a 1064 nm Nd:YAG laser: report of two cases. J Cosmet Laser Ther. 2008 Jun. 10(2):120-2. [View Abstract]
  6. Ali FR, Bakkour W, Ferguson JE, Madan V. Carbon dioxide laser ablation of dermatosis papulosa nigra: high satisfaction and few complications in patients with pigmented skin. Lasers Med Sci. 2016 Apr. 31 (3):593-5. [View Abstract]
  7. Karadag AS, Ozkanli Ş, Mansuroglu C, Ozlu E, Zemheri E. Effectiveness of the Pulse Dye Laser Treatment in a Caucasian Women With Dermatosis Papulosa Nigra. Indian J Dermatol. 2015 May-Jun. 60 (3):321. [View Abstract]
  8. Maghfour J, Ogunleye T. A Systematic Review on the Treatment of Dermatosis Papulosa Nigra. J Drugs Dermatol. 2021 Apr 1. 20 (4):467-472. [View Abstract]
  9. Furukawa F, Mizawa M, Shimizu T. Treatment of dermatosis papulosa nigra using a carbon dioxide laser. J Cosmet Dermatol. 2020 Oct. 19 (10):2572-2575. [View Abstract]
  10. Tran M, Richer V. Elective Treatment of Dermatosis Papulosa Nigra: A Review of Treatment Modalities. Skin Therapy Lett. 2020 Sep. 25 (4):1-5. [View Abstract]
  11. Carter EL, Coppola CA, Barsanti FA. A randomized, double-blind comparison of two topical anesthetic formulations prior to electrodesiccation of dermatosis papulosa nigra. Dermatol Surg. 2006 Jan. 32(1):1-6. [View Abstract]
  12. Dunwell P, Rose A. Study of the skin disease spectrum occurring in an Afro-Caribbean population. Int J Dermatol. 2003 Apr. 42(4):287-9. [View Abstract]
  13. Grimes PE, Arora S, Minus HR, Kenney JA Jr. Dermatosis papulosa nigra. Cutis. 1983 Oct. 32(4):385-6, 392. [View Abstract]
  14. Zhu MY, Wang P, Li LY, Sun YP, Shen H. [Clinical-pathological analysis of 71 cases of dermatosis papulosa nigra of Han Chinese people]. Zhonghua Yi Xue Za Zhi. 2019 Oct 8. 99 (37):2903-2906. [View Abstract]
  15. Alani A, Natarajan S. First case of dermatosis papulosa nigra in a white child. Clin Exp Dermatol. 2017 Oct. 42 (7):803-805. [View Abstract]
  16. Babapour R, Leach J, Levy H. Dermatosis papulosa nigra in a young child. Pediatr Dermatol. 1993 Dec. 10(4):356-8. [View Abstract]
  17. Andrews GC, et al. Andrews' Diseases of the Skin. 8th ed. Philadelphia, Pa: WB Saunders; 1990. 752.
  18. Elder D, et al. Lever's Histopathology of the Skin. 8th ed. Philadelphia, Pa: Lippincott-Raven; 1997. 693.
  19. Moschella SL, Hurley HJ. Dermatology. Philadelphia, Pa: WB Saunders; 1992. 2162-3.
  20. Rook A, Wilkinson DS, Ebling FJG. Textbook of Dermatology. Oxford, England: Blackwell Scientific; 1998. Vol 2: 1660-1.

Dermatosis papulosa nigra. Courtesy of DermNet New Zealand (http://www.dermnetnz.org/assets/Uploads/lesions/dpn2.jpg).

Dermatosis papulosa nigra. Courtesy of DermNet New Zealand (http://www.dermnetnz.org/assets/Uploads/lesions/dpn2.jpg).